Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hengli (botulinum toxin type A) for post-stroke upper limb spasticity
CTR20131191Phase 3Completed
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of lanbotulinumtoxin-A in Muscle spasm, sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Started Jul 2014; status: completed.
02
Drugs
lanbotulinumtoxin-A
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on CTR20131191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131191.